Skip to main content
letter
. 2020 Jul 8;5(9):1610–1611. doi: 10.1016/j.ekir.2020.06.037

Table 1.

Serum and urine biochemistry

Patient 1 Patient 2
Age, yr 47 52
Gender Male Female
Past medical history Traumatic head injury 2018, PEG-fed Diabetic nephropathy, kidney/pancreas transplant 2011
Drug therapy Meropenem Tacrolimus, mycophenolate (suspended), meropenem
Date of COVID-19 diagnosis April 3, 2020 March 26, 2020
Onset of syndrome, days after COVID diagnosis 10 3
Resolution of syndrome, d 21 18
Serum sodium, mmol/l 152 138
Serum potassium, mmol/l 3.6 2.9
Serum creatinine, μmol/l 154 90
Baseline serum creatinine, μmol/l 60 62
Serum bicarbonate, mmol/l 30 4
Serum corrected calcium, mmol/l 2.56 2.41
Serum phosphate, mmol/l 1.83 0.18
Serum magnesium, mmol/l 1.03 0.56
Serum osmolality, mosmol/l 321 ND
CRP, mg/l 74 100
Urinary FEPO4, % ND 70
Urinary retinol binding protein/creatinine ratio ND 1540
Urinary osmolality, mosmol/l 264 ND

CRP, C-reactive protein; ND, not done; PEG, percutaneous endoscopic gastrostomy.